2 unknown, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow urinastatin: new trials by email Literature Review of urinastatin trials Research Report on urinastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients Ulinastatin, Placebo - COVID-19 | Phase 1 / Phase 2 | Withdrawn | Stanford University | 2022-02-01 | 2022-03-03 | |
| The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS) ulinastatin, placebo - Acute Respiratory Distress Syndrome | Phase 2 | Unknown | Techpool Bio-Pharma Co., Ltd. | 60 | 2016-08-01 | 2018-04-20 |
| Ulinastatin in Inhalation Lung Injury ulinastatin, blank group - Inhalation Injury | Phase 2 | Unknown | Chinese PLA General Hospital | 120 | 2011-02-01 | 2011-02-01 |
COVID-19 (1) · Respiratory Distress Syndrome (1)
Chinese PLA General Hospital (1) · Stanford University (1) · Techpool Bio-Pharma Co., Ltd. (1)
China (2) · United States (1)
Kevin V Grimes, MD (1) · Yimin Li, Doctor (1)